Global Biopharmaceutical Company - Bristol Myers Squibb
The 2022 C2C4C journey covered nearly 7,000 miles traversing mountain ranges and scenic plains around the globe, and raised more than $2 million to advance cancer research.
In addition to raising nearly $1 million for the Leukemia and Lymphoma Society, our colleagues also experienced chance encounters and meaningful connections at the annual Light The Night walk.
Our colleague Royce Thomas describes his experience of living with psoriasis and how it is important to support the patient mentally.
Bristol Myers Squibb is addressing patients' needs by exploring new approaches in multiple myeloma treatment and continuing research to further improve outcomes.
Bristol Myers Squibb continues to advance research to unlock the full potential of BCMA-targeted therapies across approaches in an effort to bring new options to patients living with multiple myeloma.
Bristol Myers Squibb is continuing to examine the immune system from multiple perspectives in order to find complementary combinations of therapies that have the potential to improve outcomes for patients.
Global Patient Week
Now in its eighth year, Global Patient Week is an essential part of our culture — it unifies us and reignites our passion to do more for our patients. As the first biopharma to set aside time solely focused on the individuals we are working for each and every day, Global Patient Week is a pinnacle of our year-round vision to transform patients’ lives through science.
Evris grew up with an autoimmune disease, which began as psoriasis and developed into psoriatic arthritis. These conditions created insecurities for Evris, as he struggled to accept who he was. Now, Evris finds solace in his husband, Henrik, as they share the common bond of being patients. Hear how Evris uses what he has learned from his journey to help others.
2021 GLOBAL INCLUSION & DIVERSITY
Leading with our Value of Inclusion
Moving forward. Together.
Looking for answers?
Quick links to helpful resources.
What we are talking about on Twitter
Our company’s legacy of innovation began in the early 1800s, when our founders made it their mission to bring better health solutions to patients who needed them most. Today, we are continuing that tradition by using the latest science and technology to help improve lives through the research and development of new medicines for serious diseases.